ES2105332T3 - Polimeros quelantes. - Google Patents

Polimeros quelantes.

Info

Publication number
ES2105332T3
ES2105332T3 ES93923302T ES93923302T ES2105332T3 ES 2105332 T3 ES2105332 T3 ES 2105332T3 ES 93923302 T ES93923302 T ES 93923302T ES 93923302 T ES93923302 T ES 93923302T ES 2105332 T3 ES2105332 T3 ES 2105332T3
Authority
ES
Spain
Prior art keywords
polymer
chelating polymers
diagnostic
pursuant
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93923302T
Other languages
English (en)
Inventor
Robert A Snow
David L Ladd
John L Toner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Application granted granted Critical
Publication of ES2105332T3 publication Critical patent/ES2105332T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • C08G65/3324—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof cyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyamides (AREA)
  • Polyethers (AREA)

Abstract

SEGUN ESTA INVENCION, SE PRESENTA UN POLIMERO QUE CONTIENE UNIDADES QUE CONTIENEN EL RESIDUO DE UN AGENTE QUELANTE ENLAZADO A UNA UNIDAD DE POLI(OXIDO DE ALQUILENO) Y UN METODO PARA LA PREPARACION DEL MISMO. EL POLIMERO ES PARTICULARMENTE UTIL PARA COMPOSICIONES FORMADORAS DE IMAGENES TERAPEUTICAS Y DE DIAGNOSTICO Y COMO AGENTE ANTIESTATICO.
ES93923302T 1992-10-14 1993-10-07 Polimeros quelantes. Expired - Lifetime ES2105332T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96114692A 1992-10-14 1992-10-14

Publications (1)

Publication Number Publication Date
ES2105332T3 true ES2105332T3 (es) 1997-10-16

Family

ID=25504123

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93923302T Expired - Lifetime ES2105332T3 (es) 1992-10-14 1993-10-07 Polimeros quelantes.

Country Status (10)

Country Link
US (1) US5583206A (es)
EP (1) EP0664819B1 (es)
JP (1) JPH08502528A (es)
KR (1) KR950703582A (es)
AU (1) AU5323794A (es)
CA (1) CA2146990A1 (es)
DE (1) DE69312951T2 (es)
ES (1) ES2105332T3 (es)
HK (1) HK1001498A1 (es)
WO (1) WO1994009056A1 (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559214A (en) * 1993-05-28 1996-09-24 Sterling Winthrop Inc. Unsymmetrical complexing agents and targeting immunoreagents useful in thearpeutic and diagnostic compositions and methods
US5730968A (en) * 1994-03-31 1998-03-24 Sterling Winthrop Inc. Segmented chelating polymers as imaging and therapeutic agents
US5801228A (en) * 1995-06-07 1998-09-01 Nycomed Imaging As Polymeric contrast agents for medical imaging
US5859215A (en) * 1995-10-25 1999-01-12 Wallac Oy Biospecific binding reactants labelled with luminescent lanthanide chelates and their use
WO1998010797A2 (en) * 1996-09-12 1998-03-19 Nycomed Imaging As Marker compositions
US6153655A (en) 1998-04-17 2000-11-28 Enzon, Inc. Terminally-branched polymeric linkers and polymeric conjugates containing the same
US6896874B2 (en) * 1998-05-26 2005-05-24 Wisconsin Alumni Research Foundation MR-signal emitting coatings
US6361759B1 (en) * 1998-05-26 2002-03-26 Wisconsin Alumni Research Foundation MR signal-emitting coatings
EP1063254A1 (de) * 1999-06-25 2000-12-27 Technische Uni München, Klinikum rechts der Isar, Inst. für Experiment. Onkoligie und Therapieforschung Copolymere für den Transport von Nukleinsäuren in die Zelle
AU776715B2 (en) * 1999-06-25 2004-09-16 Christian Plank Combinations for introducing nucleic acids into cells
US6756037B2 (en) 2000-03-31 2004-06-29 Enzon, Inc. Polymer conjugates of biologically active agents and extension moieties for facilitating conjugation of biologically active agents to polymeric terminal groups
US6777387B2 (en) 2000-03-31 2004-08-17 Enzon Pharmaceuticals, Inc. Terminally-branched polymeric linkers containing extension moieties and polymeric conjugates containing the same
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
DE60223499T2 (de) * 2001-02-20 2008-10-16 Enzon, Inc. Terminal verzweigte, polymere linker und diese enthaltende polymere konjugate
US20040253292A1 (en) * 2003-04-23 2004-12-16 Wisconsin Alumni Research Foundation MR-signal emitting coatings
KR101419056B1 (ko) 2005-04-29 2014-07-11 쓰리엠 이노베이티브 프로퍼티즈 컴파니 다층 폴리우레탄 보호 필름
JP5192384B2 (ja) 2005-09-22 2013-05-08 メディバス エルエルシー ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法
JP5178520B2 (ja) 2005-09-22 2013-04-10 メディバス エルエルシー 固体ポリマー送達組成物およびその使用法
US20070156042A1 (en) * 2005-12-30 2007-07-05 Orhan Unal Medical device system and method for tracking and visualizing a medical device system under MR guidance
US8457712B2 (en) * 2005-12-30 2013-06-04 Wisconsin Alumni Research Foundation Multi-mode medical device system and methods of manufacturing and using same
DOP2007000020A (es) 2006-01-31 2007-09-15 Bayer Schering Pharma Ag Modulación de la actividad de mdl-1 para el tratamiento de enfermedades inflamatorias
US8532742B2 (en) * 2006-11-15 2013-09-10 Wisconsin Alumni Research Foundation System and method for simultaneous 3DPR device tracking and imaging under MR-guidance for therapeutic endovascular interventions
CN101541857B (zh) * 2006-11-27 2012-12-12 阿克塔马克斯手术器材有限责任公司 多官能聚环氧烷、水凝胶和组织粘合剂
US20080183070A1 (en) * 2007-01-29 2008-07-31 Wisconsin Alumni Research Foundation Multi-mode medical device system with thermal ablation capability and methods of using same
US20080208039A1 (en) * 2007-02-28 2008-08-28 Wisconsin Alumni Research Foundation System and method of performing therapeutic endovascular interventions
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
EP2072060A1 (en) 2007-12-18 2009-06-24 Institut Curie Methods and compositions for the preparation and use of toxin conjugates.
US20100004313A1 (en) * 2008-02-29 2010-01-07 Tbd Modified Poloxamers for Gene Expression and Associated Methods
WO2009137711A1 (en) * 2008-05-07 2009-11-12 Medivas, Llc Biodegradable metal-chelating polymers and vaccines
EP2161020A1 (en) * 2008-09-09 2010-03-10 Koninklijke Philips Electronics N.V. Chelating amphiphilic polymers
US20120027859A1 (en) * 2008-10-15 2012-02-02 Turnell William G Biodegradable Proline-Based Polymers
US8524457B2 (en) 2009-09-22 2013-09-03 William Patterson Method for the selection of specific affinity binders by homogeneous noncompetitive assay
US9125942B2 (en) 2010-01-19 2015-09-08 Northwestern University Paramagnetic metal-nanodiamond conjugates
US20120277517A1 (en) * 2011-04-08 2012-11-01 The Johns Hopkins University Formulation and Methods for Enhanced Interventional Image-Guided Therapy of Cancer
US20120271100A1 (en) 2011-04-14 2012-10-25 Northwestern University Compositions and methods for the detection of zinc
US9963549B2 (en) 2011-06-23 2018-05-08 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
EP2823270B1 (en) 2012-03-09 2022-05-04 Promega Corporation pH SENSORS
US20140134665A1 (en) 2012-11-15 2014-05-15 Northwestern University Compositions and methods for the detection of zinc
US9551705B2 (en) 2012-12-12 2017-01-24 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
US10168323B2 (en) 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
DK3783011T5 (da) 2013-03-15 2024-08-19 Promega Corp Aktivering af bioluminescens via strukturel komplementering
CN106062565B (zh) 2014-02-27 2018-06-08 宝洁公司 用于评估生物可利用的锌的方法
AU2015258962B2 (en) 2014-05-15 2020-07-02 Cleveland Heartlab, Inc. Compositions and methods for purification and detection of HDL and ApoA1
EP3164507B1 (en) 2014-07-02 2020-02-12 Promega Corporation Reversible metal ion chelators
US9969991B2 (en) 2014-09-12 2018-05-15 Promega Corporation Internal protein tags
EP3233067B1 (en) 2014-12-18 2019-11-06 DSM IP Assets B.V. Drug delivery system for delivery of acid sensitive drugs
RU2602502C2 (ru) * 2015-03-05 2016-11-20 Федеральное государственное бюджетное учреждение науки Институт высокомолекулярных соединений Российской академии наук Способ получения радиофармпрепаратов класса поли-n-виниламидов с металлами группы марганца
JP2018517793A (ja) 2015-04-28 2018-07-05 ローム アンド ハース エレクトロニック マテリアルズ エルエルシーＲｏｈｍ ａｎｄ Ｈａａｓ Ｅｌｅｃｔｒｏｎｉｃ Ｍａｔｅｒｉａｌｓ ＬＬＣ 電気めっき浴用の添加剤としてのビス無水物及びジアミンの反応生成物
WO2016210290A1 (en) 2015-06-26 2016-12-29 Northwestern University Gd(III)-DITHIOLANE GOLD NANOPARTICLE CONJUGATES
NL2020578B1 (en) * 2018-03-13 2019-09-20 Xeikon Mfg Nv A metal compound, use of the metal compound as a charge control agent composition and a chargeable toner composition
EP3941195A4 (en) 2019-03-20 2023-03-22 Promega Corporation PHOTOAFFINITY PROBES
US11360096B2 (en) 2019-05-16 2022-06-14 Duke University Complex BRET technique for measuring biological interactions
AU2020392245A1 (en) 2019-11-27 2022-06-23 Promega Corporation Multipartite luciferase peptides and polypeptides
US20230357266A1 (en) 2022-05-04 2023-11-09 Promega Corporation Photoactivatable compounds and uses thereof

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562161A (en) * 1968-10-08 1971-02-09 Atlantic Richfield Co Polyalkylene glycol esters of ethylene-diaminetetraacetic acid as lubricant dispersants
US3859337A (en) * 1969-06-11 1975-01-07 Stauffer Chemical Co Ethylenediaminetetraacetic acid anhydride derivatives
USRE30885E (en) * 1981-03-13 1982-03-23 Cincinnati Milacron Inc. Novel diamide and lubricants containing same
US4859777A (en) * 1981-07-01 1989-08-22 Eastman Kodak Company Terpyridine chelating agents
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
CS226911B1 (en) * 1981-10-28 1984-04-16 Jaroslav Kahovec Polymere polydonor komplexons and method of their manufacture polymere polydonor
US4423158A (en) * 1983-01-27 1983-12-27 Gelinnovation Handelsaktiebolag Ion adsorbent for metals having a coordination number greater than two
US4972837A (en) * 1983-04-26 1990-11-27 Regents Of The University Of California Contrast agents for nuclear magnetic resonance imaging
JPS59215321A (ja) * 1983-05-23 1984-12-05 Sumitomo Chem Co Ltd 二官能性配位子化合物を結合した反応性高分子
FR2550449B1 (fr) * 1983-08-12 1986-01-31 Commissariat Energie Atomique Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
US4943523A (en) * 1984-01-30 1990-07-24 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
US4602097A (en) * 1984-06-11 1986-07-22 Ulano Corporation Water soluble photoinitiator benzophenone and thioxanthenone ethoxy-ether derivatives
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4859451A (en) * 1984-10-04 1989-08-22 Salutar, Inc. Paramagnetic contrast agents for MR imaging
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
EP0184899B1 (en) * 1984-11-01 1990-04-18 Nycomed As Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4980148A (en) * 1985-02-06 1990-12-25 Mallinckrodt, Inc. Methods for enhancing magnetic resonance imaging
US4746507A (en) * 1985-04-02 1988-05-24 Salutar, Inc. EDHPA based contrast agents for MR imaging, apparatus and methods
JPH084504B2 (ja) * 1985-04-26 1996-01-24 味の素株式会社 安定化ス−パ−オキサイドジスムタ−ゼ
SE8502573D0 (sv) * 1985-05-23 1985-05-23 Jouko Kanakre Fluorescent lanthanide chelates useful as labels of physiologically active materials
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
US4909257A (en) * 1986-05-01 1990-03-20 The Regents Of The University Of California Method for attaining in vivo tissue-specific contrast by nuclear magnetic resonance imaging
US4814098A (en) * 1986-09-06 1989-03-21 Bellex Corporation Magnetic material-physiologically active substance conjugate
JPS63112622A (ja) * 1986-10-30 1988-05-17 Agency Of Ind Science & Technol 多塩基酸ポリエ−テル誘導体及びそれからなる界面活性剤
US4822594A (en) * 1987-01-27 1989-04-18 Gibby Wendell A Contrast enhancing agents for magnetic resonance images
US4933441A (en) * 1987-01-27 1990-06-12 Gibby Wendell A Contrast enhancing agents for magnetic resonance images
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
DE3855239T2 (de) * 1987-07-16 1996-10-31 Nycomed Imaging As Aminocarbonsäure und Derivate
US5202423A (en) * 1988-07-08 1993-04-13 Wallac Oy Terpyridine derivatives
US5137711A (en) * 1988-07-19 1992-08-11 Mallickrodt Medical, Inc. Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents
GB8824593D0 (en) * 1988-10-20 1988-11-23 Royal Free Hosp School Med Liposomes
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
SE465155B (sv) * 1989-12-19 1991-08-05 Exploaterings Ab Tbf Metallkelatbildande hydrofil polymer foer adsorption etc samt ett saett foer framstaellning av polymeren
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
ATE153860T1 (de) * 1990-04-10 1997-06-15 Imarx Pharmaceutical Corp Polymere und ihre verwendung als kontrastmittel bei der bilderzeugung mit magnetischer resonanz
ES2068587T3 (es) * 1990-05-30 1995-04-16 Deutsches Krebsforsch Medicamentos tumorales sustituidos con polieter.
US5077037A (en) * 1990-08-03 1991-12-31 Mallinckrodt Medical, Inc. Novel compositions for magnetic resonance imaging
US5367080A (en) * 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
US5285719A (en) * 1992-09-11 1994-02-15 Gas Research Institute Rapid frozen food thawing system
US5407657A (en) * 1992-09-22 1995-04-18 Unger; Evan C. Hybrid magnetic resonance contrast agents

Also Published As

Publication number Publication date
JPH08502528A (ja) 1996-03-19
AU5323794A (en) 1994-05-09
CA2146990A1 (en) 1994-04-28
EP0664819B1 (en) 1997-08-06
DE69312951T2 (de) 1997-12-11
HK1001498A1 (en) 1998-06-19
DE69312951D1 (de) 1997-09-11
EP0664819A1 (en) 1995-08-02
KR950703582A (ko) 1995-09-20
US5583206A (en) 1996-12-10
WO1994009056A1 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
ES2105332T3 (es) Polimeros quelantes.
ES2170872T3 (es) Composiciones limpiadoras con dendrimeros como agentes suavizantes.
WO1994008624A3 (en) Therapeutic and diagnostic imaging compositions and methods
BR9509280A (pt) Uso e composição de uma formulação contra doenças sexualmente transmitidas
ES2077971T3 (es) Formulaciones medicinales en aerosol.
DK0604848T3 (da) Hurtigtørrende gelagtigt desinficeringsmiddel til hænder og fingre
BR9915542A (pt) Conjugados de polìmero de interferon beta-1a e usos
FI104324B (fi) Menetelmä terapeuttisesti käyttökelpoisen, liukenemattoman, turpoavan polymeerisen allyyliammoniumjohdannaisen valmistamiseksi
BRPI0012588B8 (pt) copolímero em bloco, composição para suprimento de agente bioativo, e, formulação de medicamento para implantação subcutânea ou injeção intravenosa.
ES2188787T3 (es) Compuesto medicamentoso de micela copolimera y metodo para su preparacion.
ATE163863T1 (de) Gelwundverbandszusammensetzungen und verfahren zu deren gebrauch
ES2159591T3 (es) Composicion de liberacion controlada.
DE69516960D1 (de) Sulfatierte hyaluronsäure mit 0.5 bis weniger als 2 sulfate gruppen pro einheit
ES2162319T3 (es) Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
ES2132162T3 (es) Composiciones farmaceuticas que incluyen un farmaco, una sustancia polimerica reticulada, un aceite y un agente tensioactivo.
AR003928A1 (es) Comprimido del liberacion controlada
ES2159403T3 (es) Poliuretanos termoplasticos que contienen principios activos.
FI96870C (fi) Vedettömiä ihonpuhdistusaineita ja niiden käyttö
BR9406059A (pt) Composição farmacéutica e método para tratamento de uma infecção helmintica em um animal
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
ECSP045123A (es) Composición para catéteres y sus usos
DK0637327T3 (da) Polyetheramidoaminhydrogeler som hepariniserbare materialer
DE3877742D1 (de) Aufweichmittel enthaltende zusammensetzung fuer naegel.
ES2172520T3 (es) Medicamento para el tratamiento de la septicemia y del choque septico.
ES2065308T1 (es) Producto para el moldeado permanente del cabello y nuevos esteres de acido 2-hidroxi-3-mercaptopropionico reductores de la queratina capilar.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 664819

Country of ref document: ES